CIMR Team

Mr. Swamy Khoday

Mr. Swamy Khoday is a well-known industrialist and philanthropist from Bengaluru, and the founder of CIMR. As Executive Director and Joint Managing Director of Khoday India Limited, one of Karnataka's most established business houses with extensive brewing and distilling operations, he has spent decades building enterprises across the state. Yet it is his conviction in the healing potential of nature that led to the creation of CIMR.

More than thirty years ago, long before it drew scientific attention, Mr. Khoday recognised the medicinal promise of Simarouba glauca, the Laxmi Taru. Driven by a deep personal belief in its potential for cancer care, he began cultivating the plant on the outskirts of Bengaluru, nurturing what has since grown into a naturally preserved forest spanning several acres. Today that forest stands as a living germplasm and conservation site for this unique medicinal plant.

His vision did not stop at cultivation. Determined to hold traditional medicine to the highest scientific standard, Mr. Khoday sought partnership with Dr. G. Padmanaban, one of India's most distinguished biochemists, and in 2018 initiated a formal, multidisciplinary research collaboration with Dabur Research Foundation. That work led to Cypro, a standardised herbaceutical born from his original conviction.

CIMR is the continuation of that vision: a centre where traditional wisdom and modern science meet, held together by the belief that guided Mr. Khoday from the beginning, that nature, studied with rigour, has much to offer human health.

Dr. G. Padmanaban

Dr. G. Padmanaban is one of India's distinguished biochemists and a key figure in the country's biomedical research. His connection to the science behind CIMR runs deep. When the therapeutic potential of Simarouba glauca first called for rigorous scientific evaluation, it was Dr. Padmanaban who took up the enquiry, leading the early exploratory studies on the plant's extracts and uncovering the encouraging biological activity that justified deeper investigation. That foundational work opened the path to a systematic, multidisciplinary research programme and, in time, to the standardised herbaceutical now known as Cypro.

His approach embodies the conviction at the heart of CIMR: that traditional and plant-derived medicine deserves the same scientific rigour and evidence as any modern therapeutic. As Director, he provides the scientific direction that keeps our formulations and clinical approaches grounded in reproducible, standards-driven research.

Consultants